Walter's Pharmacy Recalls Atropine Ophthalmic Solution Due to Sterility Concerns
Walter's Pharmacy is recalling 22 bottles of Atropine 0.01% Ophthalmic Solution in Pennsylvania due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury or hospitalization (implied by sterility failure in ophthalmic products) fall under the Severe category.
Plain-English summary
Walter's Pharmacy is recalling 22 bottles of Atropine 0.01% Ophthalmic Solution, 15mL, prescription only. The recall was initiated because of a lack of assurance of sterility for the product.
The affected product is identified by NDC 99999-9019-09. The recall includes specific lot numbers: 112015, 112715, 113015, 120515, 120715, 121215, 121515, 122115, 010516, 010716, 010816, 011116, 012016, 012816, 012916, 020316, 020416, and 020516. The product was distributed in Pennsylvania.
Consumers who have this product should contact their healthcare provider or pharmacist for further instructions on how to proceed.
The recalled product
- Product
- Atropine 0.01% Ophth Solution, 15mL bottle, Rx only, Walter's Pharmacy 401 N 17th St Allentown, PA 610-435-4706, NDC 99999-9019-09
- Manufacturer
- Walter's Pharmacy
- Category
- Drug — Ophthalmic Solution
- Hazard
- Affected units
- 22
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: 112015
- 112715
- 113015
- 120515
- 120715
- 121215
- 121515
- 122115
- 010516
- 010716
- 010816
- 011116
- 012016
- 012816
- 012916
- 020316
- 020416
- 020516.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 13 recalled by Walter's Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Walter's Pharmacy
See all →- SevereWalter's Pharmacy Recalls Silver Nitrate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Acetylcysteine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Cefazolin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Edetate Disodium Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereRanier's Compounding Laboratory Recalls Atropine 0.01% Opth Solution
FDA (Drugs) · 2018-08-22
- SevereMartin Avenue Pharmacy Recalls Atropine Sulfate Eye Drops for Sterility Concerns
FDA (Drugs) · 2014-11-05
- LowAkorn Recalls Atropine Sulfate Ophthalmic Solution Due to Viscosity Failure
FDA (Drugs) · 2018-03-14
- SevereKey Pharmacy Recalls Atropine Sulfate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereFDA Recalls Atropine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereLeiter's Compounding Recalls Atropine Sulfate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-10-19